<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Commonly observed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is the elevated expression of the <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> (PG) synthase COX-2 </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> intestinal epithelium, the COX-2 mRNA is targeted for rapid decay through the 3'-untranslated region (3'-UTR) adenylate- and uridylate (AU)-rich element (ARE), whereas in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> ARE-mediated decay is compromised </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show that the COX-2 ARE can mediate degradation through microRNA (miRNA)-mediated regulation </plain></SENT>
<SENT sid="3" pm="."><plain>We identified miR-16 to bind the COX-2 3'-UTR and inhibit COX-2 expression by promoting rapid <z:chebi fb="2" ids="33699">mRNA</z:chebi> decay </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, miR-16 levels were decreased approximately twofold and miR-16 expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells attenuated COX-2 expression and PG synthesis </plain></SENT>
<SENT sid="5" pm="."><plain>The COX-2 ARE is also bound by the <z:chebi fb="40" ids="33697">RNA</z:chebi>-binding protein HuR </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, HuR is overexpressed and localized within the cytoplasm, where it promotes ARE-<z:chebi fb="2" ids="33699">mRNA</z:chebi> stabilization </plain></SENT>
<SENT sid="7" pm="."><plain>Under conditions of HuR overexpression, miR-16 was unable to promote rapid <z:chebi fb="2" ids="33699">mRNA</z:chebi> decay through the COX-2 ARE </plain></SENT>
<SENT sid="8" pm="."><plain>Ribonucleoprotein immunoprecipitation of HuR showed direct association with miR-16 that was reversed when cytoplasmic trafficking of HuR was inhibited </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, this interaction between HuR and miR-16 promoted the downregulation of miR-16 </plain></SENT>
<SENT sid="10" pm="."><plain>These new results identify miR-16 as a central posttranscriptional regulator of COX-2 and show the ability of elevated levels of HuR to antagonize miR-16 function </plain></SENT>
<SENT sid="11" pm="."><plain>Along with insight into altered ARE-mediated <z:chebi fb="2" ids="33699">mRNA</z:chebi> decay observed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, these findings provide a new explanation for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-derived loss of miR-16 </plain></SENT>
</text></document>